U-Dreams
Natural health product licensed in Canada
- Licence holder
- Biotrade Canada Ltd.
- NPN or DIN-HM
- 80040083
- Status
- Inactive licence
- Licence date
- 19 February 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Rehmannia glutinosa Source : Racine Extract : Extract Type TBA Extraction ratio : 10:1 Dry plant equivalent : 200 mg | Not specified | Not calculated |
| Rehmannia glutinosa Source : Racine | 20 milligramme | Not calculated |
| Piper methysticum Source : Piper methysticum - racine | 10 milligramme | Not calculated |
| Piper methysticum Source : Piper methysticum - racine Extract : Extract Type TBA Extraction ratio : 20:1 Dry plant equivalent : 200 mg | Not specified | Not calculated |
| Piper methysticum Source : Piper methysticum - racine Potency : 30 Pour cent Kavalactones | Not specified | Not calculated |
| Eriobotrya japonica Source : Feuille | 50 milligramme | Not calculated |
| Eriobotrya japonica Source : Feuille Extract : Extract Type TBA Extraction ratio : 15:1 Dry plant equivalent : 750 mg | Not specified | Not calculated |
Non-medicinal ingredients
Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps relieve nervousness (calmative/sedative); Helps promote sleep.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental altertness within 2 hours of consumption. May cause vivid dreams, gastric discomfort, and/or dizziness. Discontinue use and consult a health care practitioner if you develop symptoms of liver problems (e. unexplained fatigue, abdominal pain, fever, vomiting, dark urine, yellow eyes or skin and/or loss of appetite).
- Contre-indications
Not for use by persons under the age of 18. Do not exceed recommended dosage. Excessive consumption may impair ability to drive or operate heavy equipment. Do not consume concurrently with alcohol; Do not use if you have a history of liver disorders. Stop use immediately and consult a health care practitioner if signs of liver problem appear. Do not use if you are allergic to plants of the asteraceae/Compositae/Daisy family. Do not use if you have diarrhea or loose stools. Do not use if you have high blood pressure.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consumption with alcohol, other medications or natural health products with sedative properties is not recommended. Consult a health care practitioner if sleeplessness persists continuously for more than 3 weeks (chronic insomnia). Not for long term use. Do not exceed recommended dose. If pregnant, nursing, or taking a prescription drug, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if using conventional sedative-hypnotics, anxiolytics, MAO inhibitors or other psychopharmacologic agents, levodopa (or other drug¿s for Parkinson¿s disease) or anti-platelet agents. Consult a health care practitioner prior to use if you have any type of acute infection.
Source
Official Health Canada record, licence 80040083
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.